The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J01 | Antibacterials for systemic use | |
| 3 | J01E | Sulfonamides and trimethoprim | |
| 4 | J01EE | Combinations of sulfonamides and trimethoprim, incl. derivatives |
| Code | Title | |
|---|---|---|
| J01EE01 | Sulfamethoxazole and trimethoprim | |
| J01EE02 | Sulfadiazine and trimethoprim | |
| J01EE03 | Sulfametrole and trimethoprim | |
| J01EE04 | Sulfamoxole and trimethoprim | |
| J01EE05 | Sulfadimidine and trimethoprim | |
| J01EE06 | Sulfadiazine and tetroxoprim | |
| J01EE07 | Sulfamerazine and trimethoprim |
| Active Ingredient | Description | |
|---|---|---|
| Sulfametrole |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| BACTRIM DS Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| DUROBAC Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| SEPTRIN Concentrate for solution for infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| SEPTRIN Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| XEROPRIM Tablet | Marketing Authorisation Holder | MPI, Generic |
